Science Explorer Back to mapMap
Discussion
Institution · Asklepios Klinik Sankt Augustin

Most cited papers from Asklepios Klinik Sankt Augustin

Asklepios Klinik Sankt Augustin

What are the most cited papers from Asklepios Klinik Sankt Augustin?

The most cited paper from Asklepios Klinik Sankt Augustin is "Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis" (Nicolino Ruperto et al., 2012), with 722 citations. Next come "Treating juvenile idiopathic arthritis to target: recommendations of an international task force" (365) and "GridFlow: workflow management for grid computing" (360).

Showing 50 of 60 papers. Every paper with more than 69 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis Nicolino Ruperto et al. · New England Journal of Medicine Open access 19 Dec 2012 722
2 Treating juvenile idiopathic arthritis to target: recommendations of an international task force Angelo Ravelli et al. · Annals of the Rheumatic Diseases Open access 11 Apr 2018 365
3 GridFlow: workflow management for grid computing Junwei Cao, Stephen A. Jarvis, Shweta Saini et al. Conference paper 2003 360
4 First successful implantation of a biodegradable metal stent into the left pulmonary artery of a preterm baby Peter A. Zartner, Robert Anton Cesnjevar, Helmut Singer et al. · Catheterization and Cardiovascular Interventions 2005 351
5 Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial Hermine I. Brunner et al. · Annals of the Rheumatic Diseases Open access 17 May 2014 321
6 The cubic mouse Bernd Fröhlich, John Plate Conference paper Apr 2000 285
7 Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry Gerd Horneff, Freia De Bock, Ivan Foeldvari et al. · Annals of the Rheumatic Diseases 16 Apr 2008 279
8 Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases Adriana A. de Jesus et al. · Journal of Clinical Investigation Open access 24 Dec 2019 242
9 EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part I: Overall methodology and clinical characterisation Nicolino Ruperto et al. · Annals of the Rheumatic Diseases 13 Apr 2010 240
10 Consensus statement on clear fluids fasting for elective pediatric general anesthesia Mark L. Thomas, Christa Morrison, Richard Newton et al. · Pediatric Anesthesia 27 Apr 2018 227
11 Cause of death in adults with congenital heart disease — An analysis of the German National Register for Congenital Heart Defects Claudia C. Engelings, P. Helm, Hashim Abdul‐Khaliq et al. · International Journal of Cardiology 2 Mar 2016 196
12 Childhood supratentorial ependymomas with YAP1‐MAMLD1 fusion: an entity with characteristic clinical, radiological, cytogenetic and histopathological features Felipe Andreiuolo et al. · Brain Pathology Open access 24 Sep 2018 160
13 Antigen-positive platelet transfusion in neonatal alloimmune thrombocytopenia (NAIT) VOLKER KIEFEL · Blood Open access 11 Jan 2006 153
14 Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis Arnd Heiligenhaus et al. · Rheumatology International 14 Nov 2011 152
15 Persistence of Iatrogenic Atrial Septal Defect After Interventional Mitral Valve Repair With the MitraClip System Robert Schueler, Can Öztürk, Jan Arne Wedekind et al. · JACC: Cardiovascular Interventions Open access 18 Feb 2015 152
16 Reasoning about priorities in default logic Gerhard Brewka 1994 147
17 Age and DNA methylation subgroup as potential independent risk factors for treatment stratification in children with atypical teratoid/rhabdoid tumors Michael Christoph Frühwald et al. · Neuro-Oncology Open access 27 Dec 2019 146
18 German guidelines for the diagnosis and therapy of localized scleroderma Alexander Kreuter, Thomas M. Krieg, Margitta Worm et al. · JDDG Journal der Deutschen Dermatologischen Gesellschaft Open access 27 Jan 2016 145
19 Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study Gerd Horneff et al. · Annals of the Rheumatic Diseases Open access 22 May 2013 138
20 Preoperative fasting in children: review of existing guidelines and recent developments Peter Frykholm, Ehrenfried Schindler, Robert Sümpelmann et al. · British Journal of Anaesthesia Open access 19 Dec 2017 133
21 Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial Hermine I. Brunner et al. · Annals of the Rheumatic Diseases Open access 15 May 2017 131
22 Vitamin D deficiency is associated with higher disease activity and the risk for uveitis in juvenile idiopathic arthritis - data from a German inception cohort Claudia Sengler, Julian Zink, Jens Klotsche et al. · Arthritis Research & Therapy Open access Dec 2018 130
23 Hospital admission for diabetic ketoacidosis or severe hypoglycemia in 31 330 young patients with type 1 diabetes Beate Karges, Joachim Rosenbauer, Paul‐Martin Holterhus et al. · European Journal of Endocrinology 19 Jun 2015 129
24 Myelomeningocele — a single institute analysis of the years 2007 to 2015 Elke Januschek, Andreas Röhrig, Sandra C. Kunze et al. · Child s Nervous System 16 Apr 2016 122
25 Evidence and consensus based GKJR guidelines for the treatment of juvenile idiopathic arthritis Gregor Dueckers, Nihal Guellac, Martin N. Arbogast et al. · Clinical Immunology Open access 29 Oct 2011 117
26 Practice and consensus-based strategies in diagnosing and managing systemic juvenile idiopathic arthritis in Germany PRO-KIND SJIA project collaborators et al. · Pediatric Rheumatology Open access 22 Jan 2018 115
27 A Randomized, Double‐Blind, Placebo‐Controlled Multicenter Study of Adalimumab in Pediatric Patients With Enthesitis‐Related Arthritis Rubén Burgos‐Vargas, Shirley M. L. Tse, Gerd Horneff et al. · Arthritis Care & Research Open access 30 Jul 2015 114
28 Catheterization of the radial or brachial artery in neonates and infants Ehrenfried Schindler, BERND KOWALD, H Suess et al. · Pediatric Anesthesia 23 May 2005 113
29 Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registries Joost Frans Swart et al. · Arthritis Research & Therapy Open access Dec 2018 112
30 Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: results from the 5-year long-term extension of the phase III pivotal trials Nicolino Ruperto et al. · Annals of the Rheumatic Diseases Open access 29 Sep 2018 111
31 Experience with etanercept, tocilizumab and interleukin-1 inhibitors in systemic onset juvenile idiopathic arthritis patients from the BIKER registry Gerd Horneff, Anna Carina Schulz, Jens Klotsche et al. · Arthritis Research & Therapy Open access 22 Nov 2017 111
32 Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA) Jens Klotsche, Martina Niewerth, Johannes‐Peter Haas et al. · Annals of the Rheumatic Diseases 30 Apr 2015 107
33 Efficacy and safety of oral and parenteral methotrexate therapy in children with juvenile idiopathic arthritis: An observational study with patients from the German Methotrexate Registry Ariane Klein, Ingrid Kaul, Ivan Foeldvari et al. · Arthritis Care & Research 30 May 2012 103
34 The German National Registry of Primary Immunodeficiencies (2012–2017) Sabine M. El-Helou et al. · Frontiers in Immunology Open access150 authors 19 Jul 2019 98
35 Pharmacokinetic and safety profile of tofacitinib in children with polyarticular course juvenile idiopathic arthritis: results of a phase 1, open-label, multicenter study Nicolino Ruperto et al. · Pediatric Rheumatology Open access Dec 2017 98
36 Spinal Cord Ependymomas With MYCN Amplification Show Aggressive Clinical Behavior Amy A. Swanson, Aditya Raghunathan, Robert Brian Jenkins et al. · Journal of Neuropathology & Experimental Neurology 4 Jul 2019 95
37 Agent-based grid load balancing using performance-driven task scheduling Junwei Cao, Daniel P. Spooner, Stephen A. Jarvis et al. Conference paper 22 Mar 2004 92
38 Time of Disease‐Modifying Antirheumatic Drug Start in Juvenile Idiopathic Arthritis and the Likelihood of a Drug‐Free Remission in Young Adulthood Kirsten Minden, Gerd Horneff, Martina Niewerth et al. · Arthritis Care & Research 25 Jul 2018 90
39 The majority of newly diagnosed patients with juvenile idiopathic arthritis reach an inactive disease state within the first year of specialised care: data from a German inception cohort Claudia Sengler, Jens Klotsche, Martina Niewerth et al. · RMD Open Open access Dec 2015 88
40 Genotyping circulating tumor DNA of pediatric Hodgkin lymphoma Ann-Kathrin Desch et al. · Leukemia 20 Aug 2019 86
41 Comparison of treatment response, remission rate and drug adherence in polyarticular juvenile idiopathic arthritis patients treated with etanercept, adalimumab or tocilizumab Gerd Horneff, Ariane Klein, Jens Klotsche et al. · Arthritis Research & Therapy Open access 24 Nov 2016 86
42 Impact of clear fluid fasting on pulmonary aspiration in children undergoing general anesthesia: Results of the German prospective multicenter observational (NiKs) study Christiane E. Beck et al. · Pediatric Anesthesia Open access 13 Jun 2020 85
43 Head circumference - a useful single parameter for skull volume development in cranial growth analysis? Markus Martini, Anne Klausing, Guido Lüchters et al. · Head & Face Medicine Open access 10 Jan 2018 85
44 Double-blind, placebo-controlled randomized trial with adalimumab for treatment of juvenile onset ankylosing spondylitis (JoAS): significant short term improvement Gerd Horneff, Sigrid Fitter, Ivan Foeldvari et al. · Arthritis Research & Therapy Open access 24 Oct 2012 85
45 Decompression of Thoracic Duct: New Approach for the Treatment of Failing Fontan Viktor Hraška · The Annals of Thoracic Surgery Open access 30 Jul 2013 84
46 Atrioventricular septal defects. Analysis of short- and medium-term results. Matteo Pozzi, Jürgen Remig, R. Fimmers et al. · PubMed 1991 83
47 Efficacy and Safety of Adalimumab as the First and Second Biologic Agent in Juvenile Idiopathic Arthritis: The German Biologics JIA Registry Heinrike Schmeling, Kirsten Minden, Ivan Foeldvari et al. · Arthritis & Rheumatology 18 Jun 2014 83
48 MRP8/14 serum levels as a predictor of response to starting and stopping anti-TNF treatment in juvenile idiopathic arthritis Janneke Anink, Lisette W. A. van Suijlekom‐Smit, Marieke H. Otten et al. · Arthritis Research & Therapy Open access 5 Aug 2015 82
49 The German national registry for primary immunodeficiencies (PID) Benjamin Gathmann et al. · Clinical & Experimental Immunology Open access 15 Mar 2013 82
50 Brief Report: Clinical and Molecular Phenotypes of Low‐Penetrance Variants of NLRP 3: Diagnostic and Therapeutic Challenges Jasmin B Kuemmerle-Deschner, Deepti Verma, Theresa Endres et al. · Arthritis & Rheumatology 10 Jul 2017 81

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.